Main description:

This book is the first comprehensive approach on COVID-19 cardiac complications, both during the acute phase as well as in the long-COVID period. It provides an up-to-date and highly illustrated summary of the biology of SARS-CoV-2, the course of COVID-19, risk factors that worsen the disease in COVID-19 patients, clinical features of COVID-19 patients, COVID-19 cardiological complications, treatment, and prevention methods, and long-term cardiological aspects of COVID-19.
Chapters provide the reader with a contemporary perspective on the emerging links between COVID-19 and cardiovascular disease. In addition, this volume discusses the clinical implications and therapeutic goals in patients with COVID-19 and cardiac complications, as well as possible therapeutic options. It also offers clear recommendations on how to manage (both non- and pharmacologically) to avoid the increased number of COVID-19 related deaths due to CVD and its risk factors.

Cardiovascular Complications of COVID-19 will be the primary resource for physicians, residents, fellows, and nursed and medical students in the fields of cardiology and COVID-19/infectious diseases as well as healthcare providers that initiate preventive activities and dedicated programs.

Contents:

I. Introduction

1. Biology of SARS-CoV-2 coronavirus - origin, structure, and variants

2. COVID-19 epidemiology and differences in incidence and mortality between countries

3. Clinical symptoms and course of COVID-19

4. Risk factors of developing COVID-19 and its severe course

5. Prognosis in COVID-19 patients - statistics, risk factors

II. Cardiovascular complications of the acute phase of COVID-19

6. Myocardial injury in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment)

7. Acute coronary syndrome - destabilization of atherosclerotic plaque in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment)

8. Acute vascular injury (epidemiology, influence on prognosis, pathogenesis, treatment)

9. Myocarditis in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment)

10. Heart failure in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment)

11. Acute circulatory failure in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment)

12. Cardiomyopathy in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment)

13. Arrythmias in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment)

14. Thromboembolic events in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment)

15. Stroke in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment)

16. Pulmonary embolism after COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment)

17. Cardiac complications of drugs used in COVID-19 therapy

III. Influence of the treatment of cardiovascular diseases on the course of COVID-19

18. Omega-3 acids and COVID-19 (mechanism of action, effect on prognosis)

19. Statins and COVID-19 (mechanism of action, effect on prognosis)

20. ACEI / ARB in COVID-19 (mechanism of action, effect on prognosis)

21. Colchicine in COVID-19 (mechanism of action, effect on prognosis)

22. Antiplatelets drugs (mechanism of action, effect on prognosis)

23. Other medications (mechanism of action, effect on prognosis)

IV. Cardiovascular complications of long-COVID-19

24. Long COVID-19 - definition, epidemiology, and clinical implications

25. Cardiovascular complications of Long-COVID - prevalence, diagnosis, risk factors.

26. Cardiovascular complications of Long-COVID - management.

V. The impact of the Covid-19 pandemic on the CVD diagnosis, monitoring and outcomes.

VI. The impact of the COVID-19 pandemic on e-services and digital tools development in medicine.